VINC — Vincerx Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Vincerx Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	61.8	111	52.5	12.8	4.99
Net Total Receivables	—	—	1.37	1.29	1.04
Prepaid Expenses
Total Other Current Assets
Total Current Assets	63.1	112	56	14.7	6.41
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	4.18	3.24	2.33	0
Other Long Term Assets
Total Assets	63.2	118	59.3	18.2	8.01
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	37.8	13.9	9.16	5.61	5.28
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	37.8	17.4	11.6	7	5.28
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	25.4	100	47.7	11.2	2.72
Total Liabilities & Shareholders' Equity	63.2	118	59.3	18.2	8.01
Total Common Shares Outstanding